Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Smith Cynthia Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/15/2023 4 Smith Cynthia (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.
Txns: Exercised 2,302 restricted stock units @ $0
06/08/2023 4 Smith Cynthia (Director) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $2.85, valued at $28.5k
06/08/2023 4 Smith Cynthia (Director) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 30,000 shares @ $0
Granted 45,000 options to buy @ $1.2, valued at $54k
09/19/2022 4 Smith Cynthia (Director) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 15,000 shares @ $0
08/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/15/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/29/2021 4 Smith Cynthia (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc
Txns: Unknown transaction of 3,333 shares @ $38.25, valued at $127.5k
Disposed/sold 3,333 restricted stock units @ $0
Disposed/sold 25,000 options to buy @ $14.76, valued at $369k
Disposed/sold 25,000 options to buy @ $15.44, valued at $386k
Disposed/sold 15,000 options to buy @ $21.61, valued at $324.2k
Disposed/sold 15,000 options to buy @ $30.47, valued at $457.1k
08/18/2021 4 Smith Cynthia (Director) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 7,500 options to buy @ $13.69, valued at $102.7k
06/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
01/06/2021 4 Smith Cynthia (Director) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 2,629 options to buy @ $17.93, valued at $47.1k
10/27/2020 4 Smith Cynthia (Director) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 7,500 options to buy @ $13.52, valued at $101.4k
06/16/2020 4 Smith Cynthia (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc
Txns: Granted 3,333 restricted stock units @ $0
Granted 15,000 options to buy @ $21.61, valued at $324.2k
06/09/2020 4 Smith Cynthia (Director) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 13,700 shares @ $0
Sold 4,567 shares @ $12.1, valued at $55.3k
Granted 20,100 options to buy @ $11.96, valued at $240.4k
11/22/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2019 4 Smith Cynthia (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc
Txns: Granted 25,000 options to buy @ $15.44, valued at $386k
06/10/2019 4 Smith Cynthia (Director) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 13,700 shares @ $0
Granted 20,100 options to buy @ $4.23, valued at $85k
06/05/2019 4 Smith Cynthia (Director) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 6,073 options to buy @ $10.67, valued at $64.8k
03/29/2019 4 Smith Cynthia (Director) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 12,146 options to buy @ $12.81, valued at $155.6k
03/19/2019 3 Smith Cynthia (Director) has filed a Form 3 on Spero Therapeutics, Inc.
08/29/2018 4 Smith Cynthia (Director) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $8.25, valued at $206.3k
08/29/2018 3 Smith Cynthia (Director) has filed a Form 3 on Akebia Therapeutics, Inc.
08/15/2018 4 Smith Cynthia (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc
Txns: Granted 25,000 options to buy @ $14.76, valued at $369k
08/15/2018 3 Smith Cynthia (Director) has filed a Form 3 on Dicerna Pharmaceuticals Inc
11/04/2016 3 Form 3 - Initial statement of beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy